Breaking News Instant updates and real-time market news.

VTL

Now IMUX

$8.10 /

-0.05 (-0.61%)

05:25
08/06/18
08/06
05:25
08/06/18
05:25

Vital Therapies upgraded to Outperform from Market Perform at William Blair

William Blair analyst Y. Katherine Xu upgraded Vital Therapies to Outperform ahead of the VTL-308 readout in September. VTL-308 is the company's Phase 3 trial designed to evaluate its Elad System in subjects with severe alcoholic hepatitis.

  • 07

    Aug

TODAY'S FREE FLY STORIES

Hot Stocks
AgeX Therapeutics announces collaboration with Sernova » 08:31
05/29/20
05/29
08:31
05/29/20
08:31
AGE

AgeX Therapeutics

$0.78 /

+0.0082 (+1.06%)

AgeX Therapeutics and…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
AGE AgeX Therapeutics
$0.78 /

+0.0082 (+1.06%)

Hot Stocks
Nabriva gets 'positive' EU CHMP opinion for Xenleta for CAP treatment » 08:31
05/29/20
05/29
08:31
05/29/20
08:31
NBRV

Nabriva Therapeutics

$0.85 /

+0.0063 (+0.74%)

Nabriva Therapeutics…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
NBRV Nabriva Therapeutics
$0.85 /

+0.0063 (+0.74%)

NBRV Nabriva Therapeutics
$0.85 /

+0.0063 (+0.74%)

04/23/20 Northland
Nabriva Therapeutics price target lowered to $2.50 from $5 at Northland
04/09/20 H.C. Wainwright
Nabriva Therapeutics downgraded to Neutral from Buy at H.C. Wainwright
04/08/20 Needham
Nabriva Therapeutics downgraded to Hold from Buy at Needham
03/24/20 H.C. Wainwright
Paratek, Nabriva can benefit from DISARM Act passage, says H.C. Wainwright
NBRV Nabriva Therapeutics
$0.85 /

+0.0063 (+0.74%)

Hot Stocks
Rapt Therapeutics announces poster presentation for Phase 1/2 trial of FLX475 » 08:30
05/29/20
05/29
08:30
05/29/20
08:30
RAPT

Rapt Therapeutics

$17.51 /

-0.5 (-2.78%)

RAPT Therapeutics…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
RAPT Rapt Therapeutics
$17.51 /

-0.5 (-2.78%)

RAPT Rapt Therapeutics
$17.51 /

-0.5 (-2.78%)

05/19/20
Fly Intel: Top five analyst initiations
05/19/20 Roth Capital
Rapt CCR4 antagonist may be competitive against Dupixent, says Roth Capital
05/18/20 Cantor Fitzgerald
Rapt Therapeutics initiated with an Overweight at Cantor Fitzgerald
04/13/20
Fly Intel: Top five analyst initiations
RAPT Rapt Therapeutics
$17.51 /

-0.5 (-2.78%)

Options
One new option listing and one option delisting on May 29th » 08:30
05/29/20
05/29
08:30
05/29/20
08:30
LRMR

Larimar Therapeutics

$1.00 /

-0.155 (-13.42%)

, ZFGN

Zafgen

$0.00 /

+ (+0.00%)

New option listings for…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
LRMR Larimar Therapeutics
$1.00 /

-0.155 (-13.42%)

ZFGN Zafgen
$0.00 /

+ (+0.00%)

LRMR Larimar Therapeutics
$1.00 /

-0.155 (-13.42%)

ZFGN Zafgen
$0.00 /

+ (+0.00%)

09/06/19 Roth Capital
Zafgen downgraded to Neutral from Buy at Roth Capital
09/06/19 Wedbush
Zafgen downgraded to Neutral at Wedbush, price target slashed to 78c
09/06/19 Wedbush
Zafgen downgraded to Neutral from Outperform at Wedbush
09/05/19 JMP Securities
Zafgen downgraded to Market Perform from Outperform at JMP Securities
Hot Stocks
Athenex presents interim data from oral paclitaxel Phase II study » 08:28
05/29/20
05/29
08:28
05/29/20
08:28
ATNX

Athenex

$11.12 /

-0.35 (-3.05%)

Athenex presented interim…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
ATNX Athenex
$11.12 /

-0.35 (-3.05%)

ATNX Athenex
$11.12 /

-0.35 (-3.05%)

12/13/19 RBC Capital
Athenex oraxol OS and ORR a 'best case,' buy on weakness, says RBC Capital
12/06/19 SunTrust
Athenex initiated with a Buy at SunTrust
11/19/19 RBC Capital
Athenex gets 'third SABCS win' ahead of meeting, says RBC Capital
08/07/19 RBC Capital
Athenex's Oraxol data 'near best-case,' says RBC Capital
ATNX Athenex
$11.12 /

-0.35 (-3.05%)

ATNX Athenex
$11.12 /

-0.35 (-3.05%)

Hot Stocks
Communications Systems makes minority investment in Quortus » 08:27
05/29/20
05/29
08:27
05/29/20
08:27
JCS

Communications Systems

$5.06 /

-0.04 (-0.78%)

Communications Systems…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
Hot Stocks
Hutchison China MediTech reveals analyses on the ongoing studies of savolitinib » 08:27
05/29/20
05/29
08:27
05/29/20
08:27
HCM

Hutchison China MediTech

$21.24 /

+1.3 (+6.52%)

Hutchison China MediTech…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
HCM Hutchison China MediTech
$21.24 /

+1.3 (+6.52%)

HCM Hutchison China MediTech
$21.24 /

+1.3 (+6.52%)

03/13/20
Fly Intel: Top analyst initiations
03/12/20 Cantor Fitzgerald
Hutchison China MediTech initiated with an Overweight at Cantor Fitzgerald
02/20/20
Fly Intel: Top five analyst initiations
02/20/20 Goldman Sachs
Hutchison China MediTech initiated with a Buy at Goldman Sachs
Hot Stocks
IMV Inc. reports updated clinical response, data from DeCidE1 study » 08:27
05/29/20
05/29
08:27
05/29/20
08:27
IMV

IMV Inc.

$3.05 /

-0.09 (-2.87%)

IMV Inc. reported updated…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
IMV IMV Inc.
$3.05 /

-0.09 (-2.87%)

IMV IMV Inc.
$3.05 /

-0.09 (-2.87%)

05/18/20 Wells Fargo
IMV Inc. upgraded to Overweight on COVID-19 vaccine potential at Wells Fargo
05/18/20 Wells Fargo
IMV Inc. upgraded to Overweight from Equal Weight at Wells Fargo
05/15/20 H.C. Wainwright
IMV Inc. price target raised to $13 from $11.50 at H.C. Wainwright
04/01/20 B. Riley FBR
IMV Inc. downgraded to Neutral from Buy at B. Riley FBR
Hot Stocks
Chondrial, Zafgen complete merger, begin operations as Larimar Therapeutics » 08:27
05/29/20
05/29
08:27
05/29/20
08:27
LRMR

Larimar Therapeutics

$1.00 /

-0.155 (-13.42%)

, ZFGN

Zafgen

$0.00 /

+ (+0.00%)

Chondrial Therapeutics…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
ZFGN Zafgen
$0.00 /

+ (+0.00%)

LRMR Larimar Therapeutics
$1.00 /

-0.155 (-13.42%)

ZFGN Zafgen
$0.00 /

+ (+0.00%)

09/06/19 Roth Capital
Zafgen downgraded to Neutral from Buy at Roth Capital
09/06/19 Wedbush
Zafgen downgraded to Neutral at Wedbush, price target slashed to 78c
09/06/19 Wedbush
Zafgen downgraded to Neutral from Outperform at Wedbush
09/05/19 JMP Securities
Zafgen downgraded to Market Perform from Outperform at JMP Securities
Hot Stocks
Ligand announces expansion of Icagen license agreement with Roche » 08:26
05/29/20
05/29
08:26
05/29/20
08:26
LGND

Ligand

$100.62 /

-4.16 (-3.97%)

, RHHBY

Roche

$0.00 /

+ (+0.00%)

Ligand Pharmaceuticals…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
LGND Ligand
$100.62 /

-4.16 (-3.97%)

RHHBY Roche
$0.00 /

+ (+0.00%)

LGND Ligand
$100.62 /

-4.16 (-3.97%)

04/29/20 Craig-Hallum
Ligand has 'significant upside' if remdesivir is approved, says Craig-Hallum
04/08/20 H.C. Wainwright
Ligand price target lowered to $229 from $237 at H.C. Wainwright
04/06/20 H.C. Wainwright
H.C. Wainwright says Captisol a 'key focus' for Ligand, reiterates Buy
03/24/20 Argus
Ligand downgraded to Hold from Buy at Argus
RHHBY Roche
$0.00 /

+ (+0.00%)

05/15/20 Barclays
Roche price target raised to CHF 395 from CHF 385 at Barclays
05/14/20 Mizuho
Arcus Biosciences price target raised to $40 from $22 at Mizuho
05/13/20 Wolfe Research
Roche upgraded to Outperform from Peer Perform at Wolfe Research
05/13/20 Wolfe Research
Roche upgraded to Outperform from Peer Perform at Wolfe Research
LGND Ligand
$100.62 /

-4.16 (-3.97%)

RHHBY Roche
$0.00 /

+ (+0.00%)

RHHBY Roche
$0.00 /

+ (+0.00%)

LGND Ligand
$100.62 /

-4.16 (-3.97%)

RHHBY Roche
$0.00 /

+ (+0.00%)

Recommendations
Slack Technologies price target raised to $37 from $32 at Stephens » 08:25
05/29/20
05/29
08:25
05/29/20
08:25
WORK

Slack Technologies

$32.56 /

+0.43 (+1.34%)

Stephens analyst Ryan…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
WORK Slack Technologies
$32.56 /

+0.43 (+1.34%)

WORK Slack Technologies
$32.56 /

+0.43 (+1.34%)

05/27/20 Baird
Slack Technologies price target raised to $36 from $24 at Baird
04/16/20 Credit Suisse
Slack Technologies price target raised to $26 from $21 at Credit Suisse
04/14/20
Fly Intel: Top five analyst initiations
04/14/20 Cantor Fitzgerald
Slack Technologies initiated with an Overweight at Cantor Fitzgerald
WORK Slack Technologies
$32.56 /

+0.43 (+1.34%)

WORK Slack Technologies
$32.56 /

+0.43 (+1.34%)

WORK Slack Technologies
$32.56 /

+0.43 (+1.34%)

WORK Slack Technologies
$32.56 /

+0.43 (+1.34%)

Technical Analysis
DJ Transportation Average: Pivot points » 08:25
05/29/20
05/29
08:25
05/29/20
08:25
$DJT

DJ Transportation Average

$0.00 /

+ (+0.00%)

The following are the…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
$DJT DJ Transportation Average
$0.00 /

+ (+0.00%)

$DJT DJ Transportation Average
$0.00 /

+ (+0.00%)

Conference/Events
Allogene Therapeutics to hold a webinar » 08:25
05/29/20
05/29
08:25
05/29/20
08:25
ALLO

Allogene Therapeutics

$46.60 /

-2.43 (-4.96%)

President & CEO Chang…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
ALLO Allogene Therapeutics
$46.60 /

-2.43 (-4.96%)

ALLO Allogene Therapeutics
$46.60 /

-2.43 (-4.96%)

05/19/20 Roth Capital
Allogene Therapeutics upgraded to Buy with $60 target at Roth Capital
05/19/20 Roth Capital
Allogene Therapeutics upgraded to Buy from Neutral at Roth Capital
05/18/20 H.C. Wainwright
Precision BioSciences could have 'significant upside,' says H.C. Wainwright
05/15/20 Guggenheim
Guggenheim upgrades Allogene to Buy with $50 target after ASCO upside surprise
ALLO Allogene Therapeutics
$46.60 /

-2.43 (-4.96%)

ALLO Allogene Therapeutics
$46.60 /

-2.43 (-4.96%)

Hot Stocks
Deciphera presents results from INVICTUS pivotal Phase 3 study at ASCO » 08:24
05/29/20
05/29
08:24
05/29/20
08:24
DCPH

Deciphera

$56.94 /

-1.77 (-3.01%)

Deciphera Pharmaceuticals…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
DCPH Deciphera
$56.94 /

-1.77 (-3.01%)

DCPH Deciphera
$56.94 /

-1.77 (-3.01%)

05/18/20 SunTrust
Deciphera price target raised to $91 from $82 at SunTrust
05/18/20 Barclays
Deciphera price target raised to $85 from $80 at Barclays
05/18/20 Piper Sandler
Piper Sandler a buyer of Deciphera shares on the open
05/15/20 Piper Sandler
Deciphera's Ripretinib approved 3 months ahead of schedule, says Piper Sandler
DCPH Deciphera
$56.94 /

-1.77 (-3.01%)

DCPH Deciphera
$56.94 /

-1.77 (-3.01%)

Technical Analysis
DJ Utility Average: Pivot points » 08:24
05/29/20
05/29
08:24
05/29/20
08:24
$DJU

DJ Utility Average

$0.00 /

+ (+0.00%)

The following are the…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
$DJU DJ Utility Average
$0.00 /

+ (+0.00%)

Technical Analysis
Dow Jones Industrial Average: Pivot points » 08:24
05/29/20
05/29
08:24
05/29/20
08:24
DJX

Dow Jones Industrial Average

$0.00 /

+ (+0.00%)

The following are the…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
DJX Dow Jones Industrial Average
$0.00 /

+ (+0.00%)

DJX Dow Jones Industrial Average
$0.00 /

+ (+0.00%)

02/27/20 Keefe Bruyette
Stock market may rally Monday on 'Biden bounce,' Keefe Bruyette says
02/24/20
Dow Jones futures decline over 800 points ahead of today's open
DJX Dow Jones Industrial Average
$0.00 /

+ (+0.00%)

DJX Dow Jones Industrial Average
$0.00 /

+ (+0.00%)

Technical Analysis
iShares Transportation Average: Pivot points » 08:24
05/29/20
05/29
08:24
05/29/20
08:24
IYT

iShares Transportation Average

$159.99 /

-2.27 (-1.40%)

The following are the…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
IYT iShares Transportation Average
$159.99 /

-2.27 (-1.40%)

IYT iShares Transportation Average
$159.99 /

-2.27 (-1.40%)

IYT iShares Transportation Average
$159.99 /

-2.27 (-1.40%)

Hot Stocks
Harpoon Therapeutics presents data from dosing trial for TriTAC HPN424 at ASCO » 08:24
05/29/20
05/29
08:24
05/29/20
08:24
HARP

Harpoon Therapeutics

$20.74 /

-1.03 (-4.73%)

Harpoon Therapeutics…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
HARP Harpoon Therapeutics
$20.74 /

-1.03 (-4.73%)

HARP Harpoon Therapeutics
$20.74 /

-1.03 (-4.73%)

05/22/20 Piper Sandler
Harpoon Therapeutics initiated with an Overweight at Piper Sandler
04/16/20 Citi
Citi opens 'positive 90-day catalyst watch' on Harpoon Therapeutics
02/28/20
Fly Intel: Top five analyst initiations
02/27/20 SunTrust
Harpoon Therapeutics initiated with a Buy at SunTrust
HARP Harpoon Therapeutics
$20.74 /

-1.03 (-4.73%)

HARP Harpoon Therapeutics
$20.74 /

-1.03 (-4.73%)

HARP Harpoon Therapeutics
$20.74 /

-1.03 (-4.73%)

Technical Analysis
Technology Select Sector SPDR: Pivot points » 08:23
05/29/20
05/29
08:23
05/29/20
08:23
XLK

Technology Select Sector SPDR

$96.78 /

-0.14 (-0.14%)

The following are the…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
XLK Technology Select Sector SPDR
$96.78 /

-0.14 (-0.14%)

XLK Technology Select Sector SPDR
$96.78 /

-0.14 (-0.14%)

Hot Stocks
Vir Biotechnology, Biogen enter agreement to manufacture SARS-CoV-2 antibodies » 08:23
05/29/20
05/29
08:23
05/29/20
08:23
VIR

Vir Biotechnology

$31.58 /

-0.62 (-1.93%)

, BIIB

Biogen

$300.49 /

-0.98 (-0.33%)

Vir Biotechnology, Inc.…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
VIR Vir Biotechnology
$31.58 /

-0.62 (-1.93%)

BIIB Biogen
$300.49 /

-0.98 (-0.33%)

VIR Vir Biotechnology
$31.58 /

-0.62 (-1.93%)

05/13/20 Barclays
Vir Biotechnology price target raised to $44 from $41 at Barclays
03/19/20 JPMorgan
JPMorgan downgrades Vir Biotechnology to Underweight after 290% rally
03/19/20 JPMorgan
Vir Biotechnology downgraded to Underweight from Neutral at JPMorgan
03/13/20 Goldman Sachs
Vir Biotechnology downgraded to Neutral from Buy at Goldman Sachs
BIIB Biogen
$300.49 /

-0.98 (-0.33%)

04/23/20
Fly Intel: Top five analyst downgrades
04/23/20 Oppenheimer
Biogen price target lowered to $365 from $390 at Oppenheimer
04/23/20 Raymond James
Biogen downgraded to Underperform from Market Perform at Raymond James
04/23/20 Jefferies
Biogen may lack catalysts until more aducanumab clarity, says Jefferies
VIR Vir Biotechnology
$31.58 /

-0.62 (-1.93%)

BIIB Biogen
$300.49 /

-0.98 (-0.33%)

VIR Vir Biotechnology
$31.58 /

-0.62 (-1.93%)

BIIB Biogen
$300.49 /

-0.98 (-0.33%)

VIR Vir Biotechnology
$31.58 /

-0.62 (-1.93%)

BIIB Biogen
$300.49 /

-0.98 (-0.33%)

VIR Vir Biotechnology
$31.58 /

-0.62 (-1.93%)

BIIB Biogen
$300.49 /

-0.98 (-0.33%)

Technical Analysis
Energy Select Sector SPDR: Pivot points » 08:23
05/29/20
05/29
08:23
05/29/20
08:23
XLE

Energy Select Sector SPDR

$38.91 /

-1.14 (-2.85%)

The following are the…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
XLE Energy Select Sector SPDR
$38.91 /

-1.14 (-2.85%)

XLE Energy Select Sector SPDR
$38.91 /

-1.14 (-2.85%)

XLE Energy Select Sector SPDR
$38.91 /

-1.14 (-2.85%)

XLE Energy Select Sector SPDR
$38.91 /

-1.14 (-2.85%)

Recommendations
Dollar General price target raised to $200 from $175 at BMO Capital » 08:23
05/29/20
05/29
08:23
05/29/20
08:23
DG

Dollar General

$184.09 /

-2.715 (-1.45%)

BMO Capital analyst Kelly…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
DG Dollar General
$184.09 /

-2.715 (-1.45%)

DG Dollar General
$184.09 /

-2.715 (-1.45%)

08:20 Today Loop Capital
Dollar General price target raised to $190 from $175 at Loop Capital
05/28/20 Wells Fargo
Wells says Dollar General 'in a league of its own' after 'standout quarter'
05/26/20 Deutsche Bank
Dollar General price target raised to $187 from $159 at Deutsche Bank
05/18/20
Fly Intel: Top five analyst initiations
DG Dollar General
$184.09 /

-2.715 (-1.45%)

DG Dollar General
$184.09 /

-2.715 (-1.45%)

DG Dollar General
$184.09 /

-2.715 (-1.45%)

DG Dollar General
$184.09 /

-2.715 (-1.45%)

Technical Analysis
Consumer Discretionary Sector SPDR: Pivot points » 08:23
05/29/20
05/29
08:23
05/29/20
08:23
XLY

Consumer Discretionary Sector SPDR

$123.75 /

-1.47 (-1.17%)

The following are the…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
XLY Consumer Discretionary Sector SPDR
$123.75 /

-1.47 (-1.17%)

03/18/20
Jefferies ups Health Care to Overweight, cuts Discretionary to Underweight
XLY Consumer Discretionary Sector SPDR
$123.75 /

-1.47 (-1.17%)

Technical Analysis
S&P Select Materials SPDR: Pivot points » 08:23
05/29/20
05/29
08:23
05/29/20
08:23
XLB

S&P Select Materials SPDR

$55.45 /

+0.53 (+0.97%)

The following are the…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
XLB S&P Select Materials SPDR
$55.45 /

+0.53 (+0.97%)

XLB S&P Select Materials SPDR
$55.45 /

+0.53 (+0.97%)

Hot Stocks
Deciphera presents data from cohort of Part 2 of rebastinib Phase 1b/2 at ASCO » 08:23
05/29/20
05/29
08:23
05/29/20
08:23
DCPH

Deciphera

$56.94 /

-1.77 (-3.01%)

Deciphera Pharmaceuticals…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
DCPH Deciphera
$56.94 /

-1.77 (-3.01%)

DCPH Deciphera
$56.94 /

-1.77 (-3.01%)

05/18/20 SunTrust
Deciphera price target raised to $91 from $82 at SunTrust
05/18/20 Barclays
Deciphera price target raised to $85 from $80 at Barclays
05/18/20 Piper Sandler
Piper Sandler a buyer of Deciphera shares on the open
05/15/20 Piper Sandler
Deciphera's Ripretinib approved 3 months ahead of schedule, says Piper Sandler
DCPH Deciphera
$56.94 /

-1.77 (-3.01%)

DCPH Deciphera
$56.94 /

-1.77 (-3.01%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.